In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital

PURPOSE: Colistin is a drug of last resort for treating multidrug-resistant Acinetobacter baumannii infections. Unfortunately, colistin-resistant A. baumannii (CoR-AB) has been reported. Here, we examined the in vitro effect of mono- and combined antimicrobials against CoR-AB strains and their resis...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Infect Drug Resist
Autori principali: Lertsrisatit, Yongyut, Santimaleeworagun, Wichai, Thunyaharn, Sudaluck, Traipattanakul, Jantima
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2017
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700765/
https://ncbi.nlm.nih.gov/pubmed/29200878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S148185
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi